325 related articles for article (PubMed ID: 32324591)
1. Inhibition of stearoyl-coenzyme A desaturase 1 ameliorates hepatic steatosis by inducing AMPK-mediated lipophagy.
Zhou Y; Zhong L; Yu S; Shen W; Cai C; Yu H
Aging (Albany NY); 2020 Apr; 12(8):7350-7362. PubMed ID: 32324591
[TBL] [Abstract][Full Text] [Related]
2. Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway.
Zhu X; Bian H; Wang L; Sun X; Xu X; Yan H; Xia M; Chang X; Lu Y; Li Y; Xia P; Li X; Gao X
Free Radic Biol Med; 2019 Sep; 141():192-204. PubMed ID: 31226399
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of stearoyl-CoA desaturase1 activates AMPK and exhibits beneficial lipid metabolic effects in vitro.
Kim E; Lee JH; Ntambi JM; Hyun CK
Eur J Pharmacol; 2011 Dec; 672(1-3):38-44. PubMed ID: 21970804
[TBL] [Abstract][Full Text] [Related]
4. Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desaturase.
Li ZZ; Berk M; McIntyre TM; Feldstein AE
J Biol Chem; 2009 Feb; 284(9):5637-44. PubMed ID: 19119140
[TBL] [Abstract][Full Text] [Related]
5. Uncarboxylated Osteocalcin Decreases SCD1 by Activating AMPK to Alleviate Hepatocyte Lipid Accumulation.
Wang D; Zhang M; Xu J; Yang J
Molecules; 2023 Mar; 28(7):. PubMed ID: 37049884
[TBL] [Abstract][Full Text] [Related]
6. BTG1 ameliorates liver steatosis by decreasing stearoyl-CoA desaturase 1 (SCD1) abundance and altering hepatic lipid metabolism.
Xiao F; Deng J; Guo Y; Niu Y; Yuan F; Yu J; Chen S; Guo F
Sci Signal; 2016 May; 9(428):ra50. PubMed ID: 27188441
[TBL] [Abstract][Full Text] [Related]
7. Valdecoxib attenuates lipid-induced hepatic steatosis through autophagy-mediated suppression of endoplasmic reticulum stress.
Park SY; Cho W; Abd El-Aty AM; Hacimuftuoglu A; Jeong JH; Jung TW
Biochem Pharmacol; 2022 May; 199():115022. PubMed ID: 35358477
[TBL] [Abstract][Full Text] [Related]
8. TRIF-dependent Toll-like receptor signaling suppresses
Chen J; Li J; Yiu JHC; Lam JKW; Wong CM; Dorweiler B; Xu A; Woo CW
Sci Signal; 2017 Aug; 10(491):. PubMed ID: 28790196
[TBL] [Abstract][Full Text] [Related]
9. Carbon monoxide protects against hepatic steatosis in mice by inducing sestrin-2 via the PERK-eIF2α-ATF4 pathway.
Kim HJ; Joe Y; Kim SK; Park SU; Park J; Chen Y; Kim J; Ryu J; Cho GJ; Surh YJ; Ryter SW; Kim UH; Chung HT
Free Radic Biol Med; 2017 Sep; 110():81-91. PubMed ID: 28578014
[TBL] [Abstract][Full Text] [Related]
10. Metformin attenuates triglyceride accumulation in HepG2 cells through decreasing stearyl-coenzyme A desaturase 1 expression.
Zhu X; Yan H; Xia M; Chang X; Xu X; Wang L; Sun X; Lu Y; Bian H; Li X; Gao X
Lipids Health Dis; 2018 May; 17(1):114. PubMed ID: 29759071
[TBL] [Abstract][Full Text] [Related]
11. Hepatic stearoyl CoA desaturase 1 deficiency increases glucose uptake in adipose tissue partially through the PGC-1α-FGF21 axis in mice.
Aljohani A; Khan MI; Bonneville A; Guo C; Jeffery J; O'Neill L; Syed DN; Lewis SA; Burhans M; Mukhtar H; Ntambi JM
J Biol Chem; 2019 Dec; 294(51):19475-19485. PubMed ID: 31690632
[TBL] [Abstract][Full Text] [Related]
12. LB100 ameliorates nonalcoholic fatty liver disease
Chen XY; Cai CZ; Yu ML; Feng ZM; Zhang YW; Liu PH; Zeng H; Yu CH
World J Gastroenterol; 2019 Dec; 25(45):6607-6618. PubMed ID: 31832001
[TBL] [Abstract][Full Text] [Related]
13. Dihydromyricetin ameliorates hepatic steatosis and insulin resistance via AMPK/PGC-1α and PPARα-mediated autophagy pathway.
Yang Y; Qiu W; Xiao J; Sun J; Ren X; Jiang L
J Transl Med; 2024 Mar; 22(1):309. PubMed ID: 38532480
[TBL] [Abstract][Full Text] [Related]
14.
Kim JH; Sim HA; Jung DY; Lim EY; Kim YT; Kim BJ; Jung MH
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31569635
[No Abstract] [Full Text] [Related]
15. Barley sprout extracts reduce hepatic lipid accumulation in ethanol-fed mice by activating hepatic AMP-activated protein kinase.
Kim YJ; Hwang SH; Jia Y; Seo WD; Lee SJ
Food Res Int; 2017 Nov; 101():209-217. PubMed ID: 28941686
[TBL] [Abstract][Full Text] [Related]
16. SCD1 regulates the AMPK/SIRT1 pathway and histone acetylation through changes in adenine nucleotide metabolism in skeletal muscle.
Dziewulska A; Dobosz AM; Dobrzyn A; Smolinska A; Kolczynska K; Ntambi JM; Dobrzyn P
J Cell Physiol; 2020 Feb; 235(2):1129-1140. PubMed ID: 31241768
[TBL] [Abstract][Full Text] [Related]
17. Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease
Li CX; Gao JG; Wan XY; Chen Y; Xu CF; Feng ZM; Zeng H; Lin YM; Ma H; Xu P; Yu CH; Li YM
World J Gastroenterol; 2019 Sep; 25(34):5120-5133. PubMed ID: 31558861
[TBL] [Abstract][Full Text] [Related]
18. Exercise improves lipid droplet metabolism disorder through activation of AMPK-mediated lipophagy in NAFLD.
Li H; Dun Y; Zhang W; You B; Liu Y; Fu S; Qiu L; Cheng J; Ripley-Gonzalez JW; Liu S
Life Sci; 2021 May; 273():119314. PubMed ID: 33667513
[TBL] [Abstract][Full Text] [Related]
19. Formononetin alleviates hepatic steatosis by facilitating TFEB-mediated lysosome biogenesis and lipophagy.
Wang Y; Zhao H; Li X; Wang Q; Yan M; Zhang H; Zhao T; Zhang N; Zhang P; Peng L; Li P
J Nutr Biochem; 2019 Nov; 73():108214. PubMed ID: 31520816
[TBL] [Abstract][Full Text] [Related]
20. Loss of ULK1 increases RPS6KB1-NCOR1 repression of NR1H/LXR-mediated Scd1 transcription and augments lipotoxicity in hepatic cells.
Sinha RA; Singh BK; Zhou J; Xie S; Farah BL; Lesmana R; Ohba K; Tripathi M; Ghosh S; Hollenberg AN; Yen PM
Autophagy; 2017 Jan; 13(1):169-186. PubMed ID: 27846372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
